• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬尿氨酸途径酶氨基羧基戊烯酸半醛脱羧酶可能与治疗抵抗性抑郁症有关,患者的基线炎症状态可预测治疗反应:一项初步研究。

A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study.

机构信息

Department of Medical Biochemistry, Faculty of Medicine, Gazi University, Ankara, Turkey.

Department of Psychiatry, Faculty of Medicine, Gazi University, Ankara, Turkey.

出版信息

J Neural Transm (Vienna). 2022 Dec;129(12):1513-1526. doi: 10.1007/s00702-022-02553-x. Epub 2022 Nov 5.

DOI:10.1007/s00702-022-02553-x
PMID:36334154
Abstract

The kynurenine pathway (KP) and inflammation are substantial in depression pathogenesis. Although there is a crosstalk between the KP, inflammation, and neurotrophic factors, few studies examine these topics together. Novel medications may be developed by clarifying dysregulations related to inflammation, KP, and neurotrophic factors in treatment-resistant depression (TRD). We aimed to evaluate the serum levels of KP metabolites, proinflammatory biomarkers, and brain-derived neurotrophic factor (BDNF) in healthy controls (HC) and the patients with TRD whose followed up with three different treatments. Moreover, the effect of electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS) on biomarkers was investigated. Study groups comprised a total of 30 unipolar TRD patients consisting of three separate patient groups (ECT = 8, rTMS = 10, pharmacotherapy = 12), and 9 HC. The decision to administer only pharmacotherapy or ECT/rTMS besides pharmacotherapy was given independently of this research by psychiatrists. Blood samples and symptom scores were obtained three times for patients. At baseline, quinolinic acid (QUIN) was higher in the patients with TRD compared to HC, whereas picolinic acid (PIC), PIC/QUIN, and PIC/3-hydroxykynurenine were lower. Baseline interleukin-6 (IL-6), and high-sensitivity C-reactive protein (hsCRP) were higher in nonresponders and non-remitters. ECT had an acute effect on cytokines. In the rTMS group, tumor necrosis factor-α (TNF-α) decreased in time. PIC, QUIN, and aminocarboxymuconate-semialdehyde decarboxylase (ACMSD) enzyme may play a role in TRD pathogenesis, and have diagnostic potential. rTMS and ECT have modulatory effects on low-grade inflammation seen in TRD. Baseline inflammation severity is predictive in terms of response and remission in depression.

摘要

犬尿酸途径 (KP) 和炎症在抑郁症发病机制中起重要作用。虽然 KP、炎症和神经营养因子之间存在相互作用,但很少有研究将这些主题一起研究。通过阐明与治疗抵抗性抑郁症 (TRD) 相关的炎症、KP 和神经营养因子的失调,可能会开发出新的药物。我们旨在评估健康对照组 (HC) 和接受三种不同治疗的 TRD 患者的 KP 代谢物、促炎生物标志物和脑源性神经营养因子 (BDNF) 的血清水平。此外,还研究了电惊厥治疗 (ECT) 和重复经颅磁刺激 (rTMS) 对生物标志物的影响。研究组共包括 30 名单相 TRD 患者,分为三个单独的患者组(ECT=8,rTMS=10,药物治疗=12)和 9 名 HC。是否仅给予药物治疗或药物治疗外加 ECT/rTMS 的决定是由精神科医生独立于本研究做出的。患者的血液样本和症状评分均采集了三次。在基线时,TRD 患者的 QUIN 高于 HC,而 PIC、PIC/QUIN 和 PIC/3-羟基犬尿氨酸则较低。基线时,反应不良者和无缓解者的白细胞介素-6 (IL-6) 和高敏 C 反应蛋白 (hsCRP) 较高。ECT 对细胞因子有急性作用。rTMS 组中,TNF-α 随时间减少。PIC、QUIN 和氨基羧基脒半醛脱羧酶 (ACMSD) 酶可能在 TRD 发病机制中起作用,具有诊断潜力。rTMS 和 ECT 对 TRD 中所见的低水平炎症具有调节作用。基线炎症严重程度可预测抑郁的反应和缓解。

相似文献

1
A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study.犬尿氨酸途径酶氨基羧基戊烯酸半醛脱羧酶可能与治疗抵抗性抑郁症有关,患者的基线炎症状态可预测治疗反应:一项初步研究。
J Neural Transm (Vienna). 2022 Dec;129(12):1513-1526. doi: 10.1007/s00702-022-02553-x. Epub 2022 Nov 5.
2
Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression: A Health Technology Assessment.重复经颅磁刺激治疗难治性抑郁症:一项卫生技术评估。
Ont Health Technol Assess Ser. 2021 May 6;21(4):1-232. eCollection 2021.
3
The priming effect of repetitive transcranial magnetic stimulation on clinical response to electroconvulsive therapy in treatment-resistant depression: a randomized, double-blind, sham-controlled study.重复经颅磁刺激对电抽搐治疗抵抗性抑郁症临床反应的启动效应:一项随机、双盲、假刺激对照研究。
Psychol Med. 2023 Apr;53(5):2060-2071. doi: 10.1017/S0033291721003810. Epub 2021 Sep 28.
4
The changes in kynurenine metabolites induced by rTMS in treatment-resistant depression: A pilot study.rTMS 治疗抵抗性抑郁症患者中犬尿氨酸代谢物的变化:一项初步研究。
J Psychiatr Res. 2021 Jun;138:194-199. doi: 10.1016/j.jpsychires.2021.04.009. Epub 2021 Apr 9.
5
The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites.电抽搐治疗 (ECT) 对血清色氨酸代谢物的影响。
Brain Stimul. 2019 Sep-Oct;12(5):1135-1142. doi: 10.1016/j.brs.2019.05.018. Epub 2019 May 31.
6
Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.电休克疗法可抑制难治性抑郁症患者犬尿氨酸途径的神经毒性分支。
J Neuroinflammation. 2016 Feb 29;13(1):51. doi: 10.1186/s12974-016-0517-7.
7
Changes in the metabolites of cerebrospinal fluid induced by rTMS in treatment-resistant depression: A pilot study.rTMS 治疗抵抗性抑郁症脑脊液代谢物的变化:一项初步研究。
Psychiatry Res. 2022 Jul;313:114636. doi: 10.1016/j.psychres.2022.114636. Epub 2022 May 14.
8
Cost-Utility Analysis of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Ontario.安大略省难治性抑郁症的电抽搐治疗与重复经颅磁刺激的成本-效用分析。
Can J Psychiatry. 2020 Mar;65(3):164-173. doi: 10.1177/0706743719890167. Epub 2019 Dec 5.
9
Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.电抽搐治疗前后抑郁患者色氨酸代谢产物浓度。
Brain Behav Immun. 2020 Jan;83:153-162. doi: 10.1016/j.bbi.2019.10.005. Epub 2019 Oct 10.
10
Cost-Effectiveness Modeling of Repetitive Transcranial Magnetic Stimulation Compared to Electroconvulsive Therapy for Treatment-Resistant Depression in Singapore.新加坡重复经颅磁刺激与电休克治疗难治性抑郁症的成本效益建模
Neuromodulation. 2018 Jun;21(4):376-382. doi: 10.1111/ner.12723. Epub 2017 Nov 16.

引用本文的文献

1
Higher neutrophil-lymphocyte ratio predicts poor response to repetetive transcranial magnetic stimulation(rTMS) in treatment resistant depression.较高的中性粒细胞与淋巴细胞比值预示着难治性抑郁症患者对重复经颅磁刺激(rTMS)治疗反应不佳。
Eur Arch Psychiatry Clin Neurosci. 2025 Mar 5. doi: 10.1007/s00406-025-01977-2.
2
Effects of Repetitive Transcranial Magnetic Stimulation on Tumor Necrosis Factor Alpha in Neuropsychological Disorders: A Systematic Review and Meta-Analysis.重复经颅磁刺激对神经心理障碍中肿瘤坏死因子α的影响:一项系统评价和荟萃分析
Brain Behav. 2025 Feb;15(2):e70329. doi: 10.1002/brb3.70329.
3
Association between rTMS-induced changes in inflammatory markers and improvement in psychiatric diseases: a systematic review.
重复经颅磁刺激(rTMS)引起的炎症标志物变化与精神疾病改善之间的关联:一项系统综述
Ann Gen Psychiatry. 2024 Aug 27;23(1):31. doi: 10.1186/s12991-024-00514-0.
4
Experimental environment improves the reliability of short-latency afferent inhibition.实验环境提高了短潜伏期传入抑制的可靠性。
PLoS One. 2023 Feb 22;18(2):e0281867. doi: 10.1371/journal.pone.0281867. eCollection 2023.